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Conclusions
Children with headache may not present as the typical headache
pattern in adults. While the IHS criteria was developed primarily
for headache disorders in adults, the number of tension headache
and migraine may be underestimated in our study. A longer follow-
up period is required for establishing a definite diagnosis for the
type of headache in children. Male is more affected than girls.
This was consistent with Caucasian’s data. Co-occurrence of
other pain symptoms was commonly seen in our children.
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Spinal Muscular Atrophy (SMA) – Natural History
and Functional Status in Hong Kong Children
B. Chung, V. Wong, P. Ip, S. Hui
Division of Neurodevelopmental Paediatrics, Department of
Paediatrics and Adolescent Medicine, The University of Hong
Kong, Hong Kong
Objective
To study the natural history and current functional status of children
with SMA in Hong Kong.
Methods
A SMA Registry had been collected since 1984 in Duchess of
Kent Children’s Hospital. Families of SMA (FSMA) has
been established in 2000. A total 102 SMA cases had been
collected. We analyzed 81 SMA cases (34 males; 47 females)
with clinical information available in September 2002.
SMA cases were classi-fied according to classification of the
International SMA Consortium. SMA type III was further
classified into IIIa (onset <3 years) and IIIb (>3 years). The
validated Chinese Functional Independence Measure for
Children (WeeFIM) was administered to 39 active SMA cases
to assess their performance in daily functional skills in 3 do-
mains (self care, mobility and cognition).
Results
Our SMA Registry consisted of type I (severe) = 20 (24.7%); type
II (intermediate) = 26 (32.1%) and type III (mild) = 35 (43.2%).
The survival probability for SMA I was 55%, 40%, 30%, 30%,
30%; for type II was 100%, 100%, 100%, 92%, 88% at 1, 2, 4, 10,
and 20 years of age respectively.
The probability of being ambulatory (defined as walking
with or without assistance) at 2, 4, 10, 20 years of age for SMA II
was 64%, 59%, 32%, 5%; and 100%, 100%, 82%, 71% for
type IIIa; and 100%, 100%, 89%, 67% for type IIIb.
WeeFIM score: The total scores were 30 (N=4; mean total
quotient = 24%), 72 (N=15; mean total quotient = 57%), 94 (N=9;
mean total quotient = 75%) and 97 (N=11; mean total quotient =
78%) for types I, II IIIa and IIIb respectively.
For the domain of mobility, more than 90% of type I, II, IIIa
and 63% of those with type IIIb required assistance. Around 55%
SMA type IIIa and b cases attained functional independence in
both self-care and cognition domains.
Conclusion
The natural history of progression for Chinese SMA patients
was similar to the Caucasians. Knowledge on the prognosis
such as long term survival and functional status is important
for counseling.
Survival probability in SMA types I and II and probability of being
ambulatory for SMA types II, IIIa and IIIb
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Valproate-induced Hyperammonemic
Encephalopathy
L. Y. Chan, A. C. F. Hui, K. S. Wong
Department of Medicine, Prince of Wales Hospital, Hong Kong
Background
Valproate-induced hyperammonemic encephalopathy is un-
common with less than 30 cases reported on Medline Search. We
review the clinical, EEG and magnetic resonance spectroscopy
findings in a patient with this condition.
Case
A 35-year-old man had left parietal oligodendroglioma with
debulking surgery done in 1997. He later underwent a second
operation with postoperative radiotherapy in 2001 because of
tumour progression. Because of a generalized tonic-clonic con-
vulsion, he was put on valproate 800 mg Q8H intravenously. After
two days on this regime he developed impaired consciousness.
Urgent CT brain did not show evidence of tumour relapse but the
EEG revealed diffuse slow waves at 3-4 Hz. Valproate level was
680 umol/L, phenobarbitone 175 umol/L and ammonia level was
85 umol/L (upper limit 47 umol), rising to 113 umol/L on the next
day, along elevated live enzymes. The valproate dosage was
reduced to 300 mg Q8H, after which the patient’s improved
markedly over two days with normalization of both liver function
and EEG. MRI and MR spectroscopy later both showed no evidence
of tumour relapse or congenital urea cycle disorders.
Conclusion
Asymptomatic hyperammonaemia is a recognized feature of
chronic use of valproate. The mechanism is not completely
understood but is probably related to the inhibition effect of
ammonia on glutamate metabolism of astrocytes; this leads
to intracellular accumulation of glutamate and subsequent osmo-
tic cellular swelling. In cases sufficiently severe to cause en-
cephalopathy, the ammonia level is usually >100 umol as in
our patient. However, our patient is particularly susceptible to
the development of encephalopathy because of multiple
factors underlying including history of brain surgery and
concomitant phenobarbitone administration and valproate
induced deranged liver function which delayed the clearance of
ammonia. But the rapid improvement with reduction of val-
proate in this case highlights the importance of recognising this
complication.
Case Report: The First Reported Case of
Intracranial Vertebral Artery Angioplasty in Hong
Kong
W. C. Fong1, Y. L. Cheung2, K. W. Tang2, K. M. Cheng3,
J. H. M. Chan1, P. C. K. Li1
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Age (y)
SMA type 1 2 4 10 20 40
Survival Probability at a certain age (%)
I (N=20) 55 40 30 30 30 —
II (N=26) 100 100 100 92 88 85
Probability of being ambulatory at a certain age (%)
II (N=26) 64 64 59 32 5 —
IIIa (N=17) 100 100 100 82 71 59
IIIb (N=18) 100 100 100 89 67 67
